TickerFactsScreenerDevelopers

CytomX Therapeutics, Inc. (CTMX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$14.96M2014: -$29.77M2015: -$33.20M2016: -$59.59M2017: -$46.26M2018: -$77.87M2019: -$141.48M2020: -$80.54M2021: -$116.04M2022: -$101.33M2023: -$6.48M2024: $25.00M2025: -$22.36M-$22.36M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$22.36M-189.5%
2024$25.00M+485.5%
2023-$6.48M+93.6%
2022-$101.33M+12.7%
2021-$116.04M-44.1%
2020-$80.54M+43.1%
2019-$141.48M-81.7%
2018-$77.87M-68.3%
2017-$46.26M+22.4%
2016-$59.59M-79.5%
2015-$33.20M-11.6%
2014-$29.77M-99.0%
2013-$14.96M—